Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_assertion description "[One of such compound, crizotinib, is now approved in the United States for the treatment of lung cancer positive for ALK rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_assertion evidence source_evidence_literature NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_assertion SIO_000772 22614325 NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_assertion wasDerivedFrom befree-2016 NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_assertion wasGeneratedBy ECO_0000203 NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.
- befree-2016 importedOn "2016-02-19" NP984103.RAtxsh5lMDzJovMO7tSINhea-letk_Jj4lBuAKtH4QoXE130_provenance.